Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCS (Q69530078)
Jump to navigation
Jump to search
scientific article published on 01 July 1989
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCS |
scientific article published on 01 July 1989 |
Statements
Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCS (English)
A Osterborg
A Ahre
M Björkholm
M Björeman
G Brenning
G Gahrton
H Gyllenhammar
G Juliusson